Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/33707
Title: Predicting New-onset Exertional and Resting Hypoxemia in Fibrotic Interstitial Lung Disease.
Austin Authors: Saleem, Ferhan;Ryerson, Christopher J;Sarma, Nandini;Johannson, Kerri;Marcoux, Veronica;Fisher, Jolene;Assayag, Deborah;Manganas, Helene;Khalil, Nasreen;Morisset, Julie;Glaspole, Ian N;Goh, Nicole S L ;Oldham, Justin M;Cox, Gerard;Fell, Charlene;Gershon, Andrea S;Halayko, Andrew;Hambly, Nathan;Lok, Stacey D;Shapera, Shane;To, Teresa;Wilcox, Pearce G;Wong, Alyson W;Kolb, Martin;Khor, Yet H 
Affiliation: The University of British Columbia, 8166, Vancouver, British Columbia, Canada.;St. Martinus University, Willemstad, Curaçao
University of British Columbia, Medicine, Vancouver, British Columbia, Canada.
Oregon Health & Science University, 6684, Portland, Oregon, United States.
University of Calgary, Pulmonary Department, Calgary, Canada.
University of Saskatchewan, 7235, Medicine, Saskatoon, Saskatchewan, Canada.
McGill University, Medicine, Montreal, Quebec, Canada.
Centre Hospitalier de l'Université de Montréal, Département de Médecine, Montreal, Quebec, Canada.
Centre Hospitalier de l'Universite de Montreal, 25443, Montreal, Quebec, Canada.
Alfred Hospital, 5390, Department of Respiratory and Sleep Medicine, Melbourne, Victoria, Australia.;Centre of Research Excellence in Pulmonary Fibrosis, Brisbane, Queensland, Australia.
Respiratory and Sleep Medicine
University of Michigan, 1259, Ann Arbor, Michigan, United States.
McMaster University, 3710, Hamilton, Ontario, Canada.
University of Calgary, Division of Respiratory Medicine, Calgary, Canada.
Sunnybrook Research Institute, 282299, Toronto, Ontario, Canada.;ICES, Toronto, Ontario, Canada.
University of Manitoba, 8664, SECTION OF RESPIRATORY DISEASES, Winnipeg, Manitoba, Canada.;University of Manitoba, 8664, Biology of Breathing Group, Children's Hospital Research Institute of Manitoba, Winnipeg, Manitoba, Canada.
McMaster University, Medicine, Hamilton, Ontario, Canada.
University of Saskatchewan, 7235, Saskatoon, Canada.
University of Toronto, 7938, Toronto, Ontario, Canada.
The Hospital for Sick Children, Child Health Evaluative Sciences, Toronto, Ontario, Canada.
St Paul's Hospital, Vancouver, British Columbia, Canada.
University of British Columbia, Department of Medicine, Vancouver, British Columbia, Canada.;St. Paul's Hospital, Centre for Heart Lung Innovation, Vancouver, British Columbia, Canada.
McMaster University, Hamilton, Ontario, Canada.
Monash University, Respiratory Research@Alfred, Central Clinical School, Melbourne, Victoria, Australia.;Austin Health, 3805, Heidelberg, Victoria, Australia.
Issue Date: Dec-2023
Date: 2023
Publication information: Annals of the American Thoracic Society 2023-12; 20(12)
Abstract: Hypoxemia in fibrotic interstitial lung disease (ILD) indicates disease progression and is of prognostic significance. The onset of hypoxemia signifies disease progression and predicts mortality in fibrotic interstitial lung diseases (ILD). Accurately predicting new-onset exertional and resting hypoxemia prompts appropriate patient discussion and timely consideration of home oxygen. We derived and externally validated a risk prediction tool for both new-onset exertional and resting hypoxemia. This study used ILD registries from Canada for the derivation cohort and from Australia and United States for the validation cohort. New-onset exertional and resting hypoxemia were defined as nadir SpO2 <88% during 6-minute walk tests, resting SpO2 <88%, or the initiation of ambulatory or continuous oxygen. Candidate predictors included patient demographics, ILD subtypes, and pulmonary function. Time-varying Cox regression was used to identify the top performing prediction model according to Akaike information criterion and clinical usability. Model performance was assessed using Harrell's C-index and goodness-of-fit (GoF) likelihood ratio test. A categorized risk prediction tool was developed. The best-performing prediction model for both new-onset exertional and resting hypoxemia included age, body mass index, a diagnosis of idiopathic pulmonary fibrosis, and percent-predicted forced vital capacity and diffusing capacity of carbon monoxide. The risk prediction tool exhibited good performance for exertional hypoxemia (C-index=0.70, GoF=0.85) and resting hypoxemia (C-index=0.77, GoF=0.27) in the derivation cohort, with similar performance in the validation cohort except calibration for resting hypoxemia (GoF=0.001). This clinically applicable risk prediction tool predicted new-onset exertional and resting hypoxemia at six months in the derivation cohort and a diverse validation cohort. Suboptimal GoF in the validation cohort likely reflected overestimation of hypoxemia risk and indicated that the model is not flawed due to underestimation of hypoxemia.
URI: https://ahro.austin.org.au/austinjspui/handle/1/33707
DOI: 10.1513/AnnalsATS.202303-208OC
ORCID: 0000-0001-9262-0538
0000-0003-4957-8869
0000-0002-0246-594X
0000-0002-7865-4552
0000-0001-6932-9443
0000-0003-3837-1467
0000-0002-5434-9342
Journal: Annals of the American Thoracic Society
PubMed URL: 37676933
ISSN: 2325-6621
Type: Journal Article
Appears in Collections:Journal articles

Show full item record

Page view(s)

72
checked on Dec 25, 2024

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.